Status:
COMPLETED
Study of Episodic Breathlessness in Patients With Lung Cancer or Other Advanced Disease
Lead Sponsor:
King's College Hospital NHS Trust
Conditions:
Dyspnea
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: Gathering information about experiences of episodic breathlessness in patients with advanced disease may help doctors learn more about the disease. PURPOSE: This clinical trial is studying...
Detailed Description
OBJECTIVES: * To explore the experiences of episodic breathlessness in patients with advanced disease (i.e., primary and secondary lung cancer, chronic obstructive pulmonary disease \[COPD\], chronic...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of advanced disease as defined by the following criteria:
- Lung cancer
- Primary lung cancer at all stages (small cell lung cancer \[SCLC\] and non-small cell lung cancer \[NSCLC\])
- Cancer at any site with secondary tumor of the lung (lung metastasis)
- Chronic obstructive pulmonary disease (COPD)
- Stage III or IV of the Global Initiative for Obstructive Lung Disease (GOLD) classification, which includes the airflow limitation measured by spirometry FEV1 \< 50%, FEV1/FVC \< 0.7, and symptoms such as more severe breathlessness, reduced exercise capacity, and repeated exacerbations
- Chronic heart failure (CHF)
- NYHA class II-IV heart disease, which includes symptoms such as dyspnea or palpitation and an increasing limitation of exercise capacity or discomfort at rest
- Motor neuron disease (MND)
- All patients suffering from breathlessness
- Suffering from episodic breathlessness as defined above at any level of severity
- PATIENT CHARACTERISTICS:
- Able to give informed consent
- Able to be interviewed
- No cognitive impairment (clinically judged by the principal investigator)
- No limited comprehension of the English language
- PRIOR CONCURRENT THERAPY:
- Concurrent disease-oriented therapies (e.g., chemotherapy, radiotherapy, or surgery) allowed
Exclusion
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01138358
Start Date
January 1 2010
End Date
October 1 2012
Last Update
August 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King's College Hospital
London, England, United Kingdom, SE5 9RJ